258 related articles for article (PubMed ID: 31254169)
1. The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges.
Cortes-Dericks L; Galetta D
Cell Oncol (Dordr); 2019 Dec; 42(6):727-738. PubMed ID: 31254169
[TBL] [Abstract][Full Text] [Related]
2. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TGF-β1 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells.
Zhao X; Wu X; Qian M; Song Y; Wu D; Zhang W
Cancer Lett; 2018 Aug; 428():34-44. PubMed ID: 29702191
[TBL] [Abstract][Full Text] [Related]
4. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
5. Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration.
Zagoura D; Trohatou O; Makridakis M; Kollia A; Kokla N; Mokou M; Psaraki A; Eliopoulos AG; Vlahou A; Roubelakis MG
EBioMedicine; 2019 Jul; 45():542-552. PubMed ID: 31303498
[TBL] [Abstract][Full Text] [Related]
6. Potential implications of mesenchymal stem cells in cancer therapy.
Dai LJ; Moniri MR; Zeng ZR; Zhou JX; Rayat J; Warnock GL
Cancer Lett; 2011 Jun; 305(1):8-20. PubMed ID: 21396770
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle.
Taheri M; Tehrani HA; Dehghani S; Alibolandi M; Arefian E; Ramezani M
Med Res Rev; 2024 Jul; 44(4):1596-1661. PubMed ID: 38299924
[TBL] [Abstract][Full Text] [Related]
8. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.
Bitsika V; Roubelakis MG; Zagoura D; Trohatou O; Makridakis M; Pappa KI; Marini FC; Vlahou A; Anagnou NP
Stem Cells Dev; 2012 May; 21(7):1097-111. PubMed ID: 21988169
[TBL] [Abstract][Full Text] [Related]
9. Fetal mesenchymal stem cells in cancer therapy.
Bitsika V; Vlahou A; Roubelakis MG
Curr Stem Cell Res Ther; 2013 Mar; 8(2):133-43. PubMed ID: 23176305
[TBL] [Abstract][Full Text] [Related]
10. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
11. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
Kahmini FR; Shahgaldi S
Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells.
Han HW; Hsu SH
Acta Biomater; 2016 Sep; 42():157-167. PubMed ID: 27296841
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells as vectors for lung cancer therapy.
Kolluri KK; Laurent GJ; Janes SM
Respiration; 2013; 85(6):443-51. PubMed ID: 23711430
[TBL] [Abstract][Full Text] [Related]
16. A Trojan horse biomimetic delivery strategy using mesenchymal stem cells for PDT/PTT therapy against lung melanoma metastasis.
Ouyang X; Wang X; Kraatz HB; Ahmadi S; Gao J; Lv Y; Sun X; Huang Y
Biomater Sci; 2020 Feb; 8(4):1160-1170. PubMed ID: 31848537
[TBL] [Abstract][Full Text] [Related]
17. Myths, reality and future of mesenchymal stem cell therapy.
Poltavtseva RA; Poltavtsev AV; Lutsenko GV; Svirshchevskaya EV
Cell Tissue Res; 2019 Mar; 375(3):563-574. PubMed ID: 30456646
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model.
Jahandideh S; Khatami S; Eslami Far A; Kadivar M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1178-1187. PubMed ID: 29929400
[TBL] [Abstract][Full Text] [Related]
19. MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents-A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives.
Szewc M; Radzikowska-Bűchner E; Wdowiak P; Kozak J; Kuszta P; Niezabitowska E; Matysiak J; Kubiński K; Masłyk M
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269887
[TBL] [Abstract][Full Text] [Related]
20. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
